ERIXF News Today: Stay Updated with the Latest Telefonaktiebolaget LM Ericsson (publ) News in Real Time
Find ERIXF news now at Meyka AI. Stay informed with the latest{" "} Telefonaktiebolaget LM Ericsson (publ) stocks updates, including price news, market analysis, and expert insights.
Ericsson Repurchases 2M Shares for SEK 252M in June Buyback
Ericsson repurchases 2.025M shares for SEK 252.3M during June 1-5, 2026, as part of its SEK 15B buyback program running through March 2027.
Ericsson Expands in Africa: Zamtel Signs 5G Partnership, June 08
Ericsson and Zamtel partner on private 4G and 5G networks in Zambia to support enterprise digital transformation and next-generation connectivity.
LBGUF Earnings Beat: L E Lundbergföretagen Q2 2026 Results
LBGUF reported Q2 2026 earnings on May 21, 2026 with $2.02 EPS and $868.45M revenue. Meyka AI rates the stock B+.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD on PNK. Medical device company faces high valuation multiples despite strong 6-month gains of 40%.
BRCTF Earnings Beat: BioArctic AB (publ) Crushes Q2 2026 Estimates
BioArctic AB (BRCTF) beat Q2 2026 earnings on May 20 with EPS of $0.2514 vs. -$0.0316 estimate and $46.04M revenue vs. $20.26M expected.
NDRBF Earnings Beat: NIBE Industrier Q2 2026 Results
NDRBF beats EPS and revenue estimates in Q2 2026 earnings. NIBE Industrier reports $0.0263 EPS vs $0.0257 estimate, $1.02B revenue.
Beyond Frames Entertainment Stock Slips 1.9% Ahead of Earnings
8WP.F stock drops 1.9% to €0.207 on XETRA ahead of May 21 earnings announcement. Gaming firm faces profitability challenges.
Xvivo Perfusion AB (XVIPY) Holds $6.54 as Organ Transplant Tech Faces Valuation Pressure
XVIPY stock trades flat at $6.54 USD. Medical device maker faces elevated valuation metrics and mixed analyst outlook in healthcare sector.
BioArctic AB (BRCTF) Earnings Preview: EPS Seen at -$0.0316 on Q2 2026
BRCTF earnings preview: BioArctic AB (publ) reports May 20, 2026. EPS estimate -$0.0316, revenue $20.26M. Analyst expectations and key metrics.